{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T10:50:15Z","timestamp":1791629415472,"version":"4.3.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Microbiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      This study aimed to evaluate the effectiveness of combinations of colistin (COL) with cinnamaldehyde (CIN) or eugenol (EUG) against planktonic and biofilm forms of colistin-resistant clinical\n                      <jats:italic>Acinetobacter baumannii<\/jats:italic>\n                      isolates.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Minimum inhibitory concentration (MIC) values of COL and essential oil components in 10 colistin-resistant clinical isolates were evaluated by the broth microdilution method. Interactions were classified by the fractional inhibitory concentration index (\u03a3FICI) using the checkerboard method. Biofilm formation was detected using the crystal violet method and the inhibitory effects of selected combination ratios on biofilm formation were evaluated in isolates showing synergy. In addition, the time-dependent effects of synergy combinations on 48-h pre-formed biofilm biomass were examined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Median MIC values of COL, CIN, and EUG were 8 (4\u201332), 128 (128\u2013128), and 512 (256\u20131024) \u00b5g\/mL, respectively. In combination, the MIC of COL decreased to 1 (0.5\u201316) \u00b5g\/mL with CIN and to 2 (0.5-8) \u00b5g\/mL with EUG (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002). Synergy was observed in half of the isolates in both combinations (median \u03a3FICI: 0.532 and 0.469). Three isolates formed strong biofilms and seven formed moderate biofilms. Biofilm inhibition ranged from 1.1% to 50.5% for COL-CIN combination and from 11.7% to 80.0% for the COL-EUG combination. In 48-h pre-formed biofilms, the residual biomass at 24\u00a0h was significantly lower than that at 1\u00a0h for both combinations (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      COL-CIN and COL-EUG combinations reduced MICs in colistin-resistant\n                      <jats:italic>A. baumannii<\/jats:italic>\n                      and decreased both biofilm formation and 48-h pre-formed biofilm biomass. These findings are promising for combination-based antibiofilm strategies.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10123-026-00848-7","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T02:04:55Z","timestamp":1781143495000},"page":"1319-1328","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Synergistic and antibiofilm activity of colistin combined with cinnamaldehyde and eugenol against colistin-resistant Acinetobacter baumannii clinical isolates"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6423-9609","authenticated-orcid":false,"given":"Abdulhamit","family":"\u00c7al\u0131","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5843-626X","authenticated-orcid":false,"given":"Rukiye","family":"Aslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3260-5309","authenticated-orcid":false,"given":"K\u00fcbra F\u0131rt\u0131na","family":"Topcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7141-5874","authenticated-orcid":false,"given":"Cem","family":"\u00c7elik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"848_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/mbo3.70046","volume":"14","author":"FM Ak\u0131ll\u0131","year":"2025","unstructured":"Ak\u0131ll\u0131 FM, \u0130lki A (2025) Evaluation of colistin susceptibility in carbapenem-resistant Acinetobacter baumannii isolates using broth microdilution, MICRONAUT\u2010MIC\u2010Strip, and VITEK MS. Microbiol Open 14:e70046. https:\/\/doi.org\/10.1002\/mbo3.70046","journal-title":"Microbiol Open"},{"key":"848_CR2","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1080\/08927014.2024.2381587","volume":"40","author":"A \u00c7al\u0131","year":"2024","unstructured":"\u00c7al\u0131 A, \u00c7elik C (2024) Determination of in vitro synergy and antibiofilm activities of antimicrobials and essential oil components. Biofouling 40:483\u2013498. https:\/\/doi.org\/10.1080\/08927014.2024.2381587","journal-title":"Biofouling"},{"key":"848_CR3","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.2147\/IDR.S309912","volume":"14","author":"L Chen","year":"2021","unstructured":"Chen L, Yu K, Chen L et al (2021) Synergistic activity and biofilm formation effect of colistin combined with PFK-158 against colistin-resistant Gram-negative bacteria. Infect Drug Resist 14:2143\u20132154. https:\/\/doi.org\/10.2147\/IDR.S309912","journal-title":"Infect Drug Resist"},{"key":"848_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.bbrc.2022.10.095","volume":"636","author":"M Choudhary","year":"2022","unstructured":"Choudhary M, Shrivastava R, Vashistt J (2022) Eugenol and geraniol impede Csu-pilus assembly and evades multidrug-resistant Acinetobacter baumannii biofilms: in-vitro and in-silico evidence. Biochem Biophys Res Commun 636:10\u201317. https:\/\/doi.org\/10.1016\/j.bbrc.2022.10.095","journal-title":"Biochem Biophys Res Commun"},{"key":"848_CR5","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1128\/jcm.22.6.996-1006.1985","volume":"22","author":"GD Christensen","year":"1985","unstructured":"Christensen GD, Simpson WA, Younger JJ et al (1985) Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol 22:996\u20131006","journal-title":"J Clin Microbiol"},{"key":"848_CR6","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/j.1472-765X.2012.03236.x","volume":"54","author":"S Chusri","year":"2012","unstructured":"Chusri S, Phatthalung PN, Voravuthikunchai SP (2012) Anti-biofilm activity of Quercus infectoria G. Olivier against methicillin\u2010resistant Staphylococcus aureus. Lett Appl Microbiol 54:511\u2013517. https:\/\/doi.org\/10.1111\/j.1472-765X.2012.03236.x","journal-title":"Lett Appl Microbiol"},{"key":"848_CR8","unstructured":"EUCAST (2022) Media preparation for EUCAST disk diffusion testing and for determination of MIC values by the broth microdilution method. Version 7.0. January"},{"key":"848_CR7","unstructured":"EUCAST (2025) European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 15.0"},{"key":"848_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/plants13020192","volume":"13","author":"N Ferrando","year":"2024","unstructured":"Ferrando N, Pino-Ot\u00edn MR, Ballestero D et al (2024) Enhancing commercial antibiotics with Trans-Cinnamaldehyde in Gram-positive and Gram-negative bacteria: an in vitro approach. Plants 13:192. https:\/\/doi.org\/10.3390\/plants13020192","journal-title":"Plants"},{"key":"848_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.989667","author":"T Gani\u0107","year":"2022","unstructured":"Gani\u0107 T, Vuleti\u0107 S, Nikoli\u0107 B et al (2022) Cinnamon essential oil and its emulsion as efficient antibiofilm agents to combat Acinetobacter baumannii. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2022.989667","journal-title":"Front Microbiol"},{"key":"848_CR11","doi-asserted-by":"publisher","unstructured":"Gedefie A, Demsiss W, Belete MA, et al (2021) Acinetobacter baumannii Biofilm Formation and Its Role in Disease Pathogenesis: A Review. IDR Volume 14:3711\u20133719. https:\/\/doi.org\/10.2147\/IDR.S332051","DOI":"10.2147\/IDR.S332051"},{"key":"848_CR12","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1128\/AAC.01393-12","volume":"57","author":"W Hengzhuang","year":"2013","unstructured":"Hengzhuang W, Ciofu O, Yang L et al (2013) High \u03b2-lactamase levels change the pharmacodynamics of \u03b2-lactam antibiotics in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 57:196\u2013204. https:\/\/doi.org\/10.1128\/AAC.01393-12","journal-title":"Antimicrob Agents Chemother"},{"key":"848_CR13","doi-asserted-by":"publisher","unstructured":"Ibrahim AA, Mohammed RK (2025) In vitro and Molecular Study of Synergistic Impact of Eugenol and Fosfomycin against Clinically-isolated, Fosfomycin-Resistant Escherichia coli. Iraqi Journal of Science 575\u2013593. https:\/\/doi.org\/10.24996\/ijs.2025.66.2.4","DOI":"10.24996\/ijs.2025.66.2.4"},{"key":"848_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens13121049","volume":"13","author":"MM Islam","year":"2024","unstructured":"Islam MM, Jung DE, Shin WS, Oh MH (2024) Colistin resistance mechanism and management strategies of colistin-resistant Acinetobacter baumannii infections. Pathogens 13:1049. https:\/\/doi.org\/10.3390\/pathogens13121049","journal-title":"Pathogens"},{"key":"848_CR15","doi-asserted-by":"publisher","DOI":"10.1155\/ijm\/1009049","volume":"2025","author":"K Javadi","year":"2025","unstructured":"Javadi K, Ghaemian P, Baziboron M, Pournajaf A (2025) Investigating the link between biofilm formation and antibiotic resistance in clinical isolates of Acinetobacter baumannii. Int J Microbiol 2025:1009049. https:\/\/doi.org\/10.1155\/ijm\/1009049","journal-title":"Int J Microbiol"},{"key":"848_CR16","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1002\/ptr.5713","volume":"30","author":"DP Karumathil","year":"2016","unstructured":"Karumathil DP, Surendran-Nair M, Venkitanarayanan K (2016) Efficacy of trans-cinnamaldehyde and eugenol in reducing Acinetobacter baumannii adhesion to and invasion of human keratinocytes and controlling wound infection in vitro. Phytother Res 30:2053\u20132059. https:\/\/doi.org\/10.1002\/ptr.5713","journal-title":"Phytother Res"},{"key":"848_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14010068","volume":"14","author":"V Khwaza","year":"2025","unstructured":"Khwaza V, Aderibigbe BA (2025) Antibacterial activity of selected essential oil components and their derivatives: a review. Antibiotics Basel 14:68. https:\/\/doi.org\/10.3390\/antibiotics14010068","journal-title":"Antibiotics Basel"},{"key":"848_CR18","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/jac\/49.2.345","volume":"49","author":"RE Lewis","year":"2002","unstructured":"Lewis RE, Diekema DJ, Messer SA (2002) Comparison of Etest, chequerboard dilution and time\u2013kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species. J Antimicrob Chemother 49:345\u2013351. https:\/\/doi.org\/10.1093\/jac\/49.2.345","journal-title":"J Antimicrob Chemother"},{"key":"848_CR19","doi-asserted-by":"publisher","unstructured":"Liu W, Chen G, Dou K, et al (2023) Eugenol eliminates carbapenem-resistant Klebsiella pneumoniae via reactive oxygen species mechanism. Front Microbiol 14:. https:\/\/doi.org\/10.3389\/fmicb.2023.1090787","DOI":"10.3389\/fmicb.2023.1090787"},{"key":"848_CR20","doi-asserted-by":"publisher","unstructured":"Luna-De-Alba A, Flores-Trevi\u00f1o S, Camacho-Ortiz A, et al (2024) Genetic Characterization of Multidrug-Resistant Acinetobacter baumannii and Synergy Assessment of Antimicrobial Combinations. Antibiotics 13:1079. https:\/\/doi.org\/10.3390\/antibiotics13111079","DOI":"10.3390\/antibiotics13111079"},{"key":"848_CR21","doi-asserted-by":"publisher","unstructured":"Migliaccio A, Stabile M, Triassi M, et al (2024) Inhibition of biofilm formation and preformed biofilm in Acinetobacter baumannii by resveratrol, chlorhexidine and benzalkonium: modulation of efflux pump activity. Front Microbiol 15:. https:\/\/doi.org\/10.3389\/fmicb.2024.1494772","DOI":"10.3389\/fmicb.2024.1494772"},{"key":"848_CR22","doi-asserted-by":"publisher","unstructured":"Mireles NA, Malla CF, Tav\u00edo MM (2024) Cinnamaldehyde and baicalin reverse colistin resistance in Enterobacterales and Acinetobacter baumannii strains. Eur J Clin Microbiol Infect Dis 43:1899\u20131908. https:\/\/doi.org\/10.1007\/s10096-024-04884-x","DOI":"10.1007\/s10096-024-04884-x"},{"key":"848_CR23","doi-asserted-by":"publisher","unstructured":"Molina Panadero I, Moreno Rodr\u00edguez A, Rey Hidalgo A, et al (2025) ENOblock synergizes with colistin to treat Acinetobacter baumannii infections. EMBO Mol Med 17:3496\u20133524. https:\/\/doi.org\/10.1038\/s44321-025-00331-2","DOI":"10.1038\/s44321-025-00331-2"},{"key":"848_CR24","doi-asserted-by":"publisher","unstructured":"Novovi\u0107 K, Jov\u010di\u0107 B (2023) Colistin Resistance in Acinetobacter baumannii: Molecular Mechanisms and Epidemiology. Antibiotics 12:516. https:\/\/doi.org\/10.3390\/antibiotics12030516","DOI":"10.3390\/antibiotics12030516"},{"key":"848_CR25","doi-asserted-by":"publisher","unstructured":"Papazachariou A, Tziolos R-N, Karakonstantis S, et al (2024) Treatment Strategies of Colistin Resistance Acinetobacter baumannii Infections. Antibiotics 13:423. https:\/\/doi.org\/10.3390\/antibiotics13050423","DOI":"10.3390\/antibiotics13050423"},{"key":"848_CR26","doi-asserted-by":"publisher","unstructured":"Pompilio A, Scribano D, Sarshar M, et al (2021) Gram-Negative Bacteria Holding Together in a Biofilm: The Acinetobacter baumannii Way. Microorganisms 9:1353. https:\/\/doi.org\/10.3390\/microorganisms9071353","DOI":"10.3390\/microorganisms9071353"},{"key":"848_CR27","doi-asserted-by":"publisher","unstructured":"Russo A, Serapide F (2025) The Multifaceted Landscape of Healthcare-Associated Infections Caused by Carbapenem-Resistant Acinetobacter baumannii. Microorganisms 13:829. https:\/\/doi.org\/10.3390\/microorganisms13040829","DOI":"10.3390\/microorganisms13040829"},{"key":"848_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14010085","volume":"14","author":"VC Scoffone","year":"2025","unstructured":"Scoffone VC, Trespidi G, Barbieri G et al (2025) The evolution of antimicrobial resistance in Acinetobacter baumannii and new strategies to fight it. Antibiotics 14:85. https:\/\/doi.org\/10.3390\/antibiotics14010085","journal-title":"Antibiotics"},{"key":"848_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29061225","volume":"29","author":"S Simbu","year":"2024","unstructured":"Simbu S, Orchard A, van Vuuren S (2024) Essential oil compounds in combination with conventional antibiotics for dermatology. Molecules 29:1225. https:\/\/doi.org\/10.3390\/molecules29061225","journal-title":"Molecules"},{"key":"848_CR30","doi-asserted-by":"publisher","first-page":"116","DOI":"10.25303\/1906rjbt01160126","volume":"19","author":"L Subathra","year":"2024","unstructured":"Subathra L, Varsha M, Visali K et al (2024) Synergistic quorum quenching activity of cinnamaldehyde against biofilm forming Pseudomonas aeruginosa. Res J Biotech 19:116\u2013126. https:\/\/doi.org\/10.25303\/1906rjbt01160126","journal-title":"Res J Biotech"},{"key":"848_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110606","volume":"130","author":"JC V\u00e1zquez-Ucha","year":"2020","unstructured":"V\u00e1zquez-Ucha JC, Mart\u00ednez-Guiti\u00e1n M, Lasarte-Monterrubio C et al (2020) Syzygium aromaticum (clove) and Thymus zygis (thyme) essential oils increase susceptibility to colistin in the nosocomial pathogens Acinetobacter baumannii and Klebsiella pneumoniae. Biomed Pharmacother 130:110606. https:\/\/doi.org\/10.1016\/j.biopha.2020.110606","journal-title":"Biomed Pharmacother"},{"key":"848_CR32","volume-title":"WHO Bacterial Priority Pathogens List 2024: Bacterial Pathogens of Public Health Importance, to Guide Research, Development, and Strategies to Prevent and Control Antimicrobial Resistance","author":"WHO","year":"2024","unstructured":"WHO (2024) WHO Bacterial Priority Pathogens List 2024: Bacterial Pathogens of Public Health Importance, to Guide Research, Development, and Strategies to Prevent and Control Antimicrobial Resistance. World Health Organization, Geneva"},{"key":"848_CR33","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00937-22","volume":"10","author":"M Xie","year":"2022","unstructured":"Xie M, Chen K, Chan E-C, Chen S (2022) Synergistic antimicrobial effect of colistin in combination with econazole against multidrug-resistant Acinetobacter baumannii and its persisters. Microbiol Spectr 10:e00937-22. https:\/\/doi.org\/10.1128\/spectrum.00937-22","journal-title":"Microbiol Spectr"},{"key":"848_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1565965","author":"A Yehya","year":"2025","unstructured":"Yehya A, Ezzeddine Z, Chakkour M et al (2025) The intricacies of Acinetobacter baumannii: a multifaceted comprehensive review of a multidrug-resistant pathogen and its clinical significance and implications. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2025.1565965","journal-title":"Front Microbiol"}],"container-title":["International Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10123-026-00848-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10123-026-00848-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10123-026-00848-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T10:20:24Z","timestamp":1791627624000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10123-026-00848-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":34,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["848"],"URL":"https:\/\/doi.org\/10.1007\/s10123-026-00848-7","relation":{},"ISSN":["1618-1905"],"issn-type":[{"value":"1618-1905","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"25 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was reviewed and approved by the Health Science Research Ethics Committee of Sivas Cumhuriyet University (Date: 08.01.2026; Decision Number: 2026-01\/29).","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}